These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115. Noguchi S, Takatsuka D, Kitamura Y, Terada N, Uchida N, Yamaguchi K, Sato B, Matsumoto K. Cancer Res; 1985 Oct; 45(10):4785-90. PubMed ID: 4027967 [Abstract] [Full Text] [Related]
4. Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice. Uchida N, Yamaguchi K, Narita N, Nakao K, Kitamura Y, Matsumoto K. Breast Cancer Res Treat; 1981 Oct; 1(1):69-75. PubMed ID: 7348566 [Abstract] [Full Text] [Related]
5. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115. Noguchi S, Kitamura Y, Uchida N, Yamaguchi K, Sato B, Matsumoto K. Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825 [Abstract] [Full Text] [Related]
6. Stimulative effect of physiological doses of androgen or pharmacological doses of estrogen on growth of Shionogi carcinoma 115 in mice. Noguchi S, Nishizawa Y, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K. Cancer Res; 1985 Nov; 45(11 Pt 2):5746-50. PubMed ID: 4053046 [Abstract] [Full Text] [Related]
10. Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model. Miyake H, Tolcher A, Gleave ME. Cancer Res; 1999 Aug 15; 59(16):4030-4. PubMed ID: 10463603 [Abstract] [Full Text] [Related]
11. Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins. Nickerson T, Miyake H, Gleave ME, Pollak M. Cancer Res; 1999 Jul 15; 59(14):3392-5. PubMed ID: 10416600 [Abstract] [Full Text] [Related]
12. Effect of androgen depletion on growth and androgen dependency of Shionogi carcinoma 115. Kitamura Y, Okamoto S, Uchida N, Yamaguchi K, Matsumoto K. Cancer Res; 1978 Dec 15; 38(12):4711-6. PubMed ID: 719647 [No Abstract] [Full Text] [Related]
13. Neoadjuvant androgen withdrawal therapy decreases local recurrence rates following tumor excision in the Shionogi tumor model. Gleave ME, Sato N, Goldenberg SL, Stothers L, Bruchovsky N, Sullivan LD. J Urol; 1997 May 15; 157(5):1727-30. PubMed ID: 9112514 [Abstract] [Full Text] [Related]
14. Development of androgen-independent spindle cell tumors from androgen-dependent medullary Shionogi carcinoma 115 in androgen-depleted nude mice. Kitamura Y, Okamoto S, Hayata I, Uchida N, Yamaguchi K, Matsumoto K. Cancer Res; 1979 Nov 15; 39(11):4713-9. PubMed ID: 498097 [Abstract] [Full Text] [Related]
15. Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence. Bruchovsky N, Rennie PS, Otal N, Vanson A, Giles M, Pontifex H. Cancer Res; 1985 Feb 15; 45(2):682-9. PubMed ID: 3967243 [Abstract] [Full Text] [Related]
20. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline. Hara T, Nakamura K, Araki H, Kusaka M, Yamaoka M. Cancer Res; 2003 Sep 01; 63(17):5622-8. PubMed ID: 14500404 [Abstract] [Full Text] [Related] Page: [Next] [New Search]